Pharmalittle: Gilead to boost remdesivir supplies in Europe; drug makers announcing $1 billion antibiotic innovation fund

Gilead Sciences plans to make more of its remdesivir, an experimental Covid-19 treatment, available for Europe as of this autumn.

A moment of truth arrives for CytoDyn’s Covid-19 drug. Don’t let spin obscure it

CytoDyn is nearing the completion of a clinical trial investigating the use of leronlimab, its repurposed and still experimental HIV drug. @adamfeurstein has its doubts.

Pharmalittle: Will a coronavirus vaccine be budget-breaking? Europe has deals with Merck and Roche for Covid-19 drugs

The European Commission reached agreements with Roche and Merck to supply two drugs to treat severely ill Covid-19 patients.

Pharmalittle: Covid-19 trials are marked by disorganization; FDA approves a new type of HIV treatment

The FDA approved a new type of HIV treatment from ViiV Healthcare intended for older people with the virus, who have been on antiretroviral therapy for so long it is starting to fail.

Data show panic and disorganization dominate the study of Covid-19 drugs

A new STAT analysis shows about 38% of the studies registered to study Covid-19 treatments have not actually begun enrolling patients.

Listen: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life

What's a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care? All that and more on the latest episode of "The Readout LOUD" podcast. Listen now: #TheReadoutLOUD

Pfizer sets the bar for Covid vaccines. Plus: an idea for cheap remdesivir, & a curious commencement address

Welcome to The Readout, your guide to what's new in biotech.

A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution

U.S. government scientists helped invent remdesivir, and HHS has a legal and moral duty to ensure access to it in the U.S. and around the world. It has the policy tool it needs to do that.

Pharmalittle: FDA sets Covid-19 vaccine guidance; White House grabs much of the remdesivir supply

The FDA released guidance for approving a Covid-19 vaccine, saying the vaccine has to prevent or decrease disease severity in at least 50% of people who are inoculated.

Some U.S. government contracts for Covid-19 research could skirt affordable pricing laws

The agreements could allow authorities to bypass laws that could ensure taxpayer-funded medicines or vaccines are affordable, according to a new report from @KEI_DC.

Pharmalittle: FDA to issue guidance on Covid-19 vaccines; what remdesivir pricing may really mean

Gilead Sciences, in a self-described effort to do “the right and responsible thing,” may have just set a precedent its industry peers will come to resent.

Gilead’s pricing for remdesivir raises questions about the drug’s long-term prospects

“The bad news is that the pricing is remarkably low, given the direct medical value, not to mention the societal value,” SVB Leerink analyst Geoffrey Porges.

How Gilead’s remdesivir price could come back to haunt the drug industry

Gilead Sciences, in a self-described effort to do “the right and responsible thing” on pricing remdesivir, may have just set a precedent its industry peers will come to resent.

Pharmalittle: Pharma giants plan $1 billion antibiotic venture; Gilead prices remdesivir below most estimates

Several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies and their nascent products.

Gilead announces remdesivir price & novel antibiotics get $1 billion

Welcome to The Readout, your guide to what's new in biotech.

Gilead announces long-awaited price for Covid-19 drug remdesivir

Gilead has announced the long-awaited price for remdesivir, the first medicine shown to have an impact on Covid-19.

Experts are calling for a 9/11-style commission on U.S. coronavirus response. Here’s where it could start

The list of missteps in the U.S. response to the Covid-19 pandemic is long. Here’s where a Sept. 11-style commission could start investigating.

Pharmalittle: Sanofi to cut hundreds of jobs; former BARDA chief claims Azar is sabotaging his new job

Sanofi is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days.

As Covid-19 cases peak, a virus once again takes advantage of human instinct

Researchers have learned a lot about SARS-CoV-2, including how it spreads, and how to test for it. But they have also learned that the virus takes advantage of human instinct.

Pharmalittle: NIH may own patents for the Moderna Covid-19 vaccine; ICER boosts recommended price for remdesivir

ICER says remdesivir, the experimental Gilead Covid-19 treatment, could be priced up to $5,080 per course based on benefits shown in patients, above its prior recommendation.

Pharmalittle: Sanofi steps up Covid-19 vaccine efforts; has a successor to FDA’s Janet Woodcock been found?

Janet Woodcock, one of the most powerful FDA regulators, has an almost mythic reputation and an outsized personality to match. Who could possibly succeed her? Now there's an answer.

Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs

“We have good reason to be skeptical about the role of the pharmaceutical industry," said Jan Schakowsky (D-Ill.), a co-sponsor of the new legislation.

Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose

Health experts are worried about whether coronavirus vaccines under development will adequately protect the elderly.

Pharmalittle: Trump pushes for Covid-19 vaccine by year’s end; Americans fear pharma will keep raising drug prices

President Trump is prodding top health officials to move faster on a historically ambitious timeline to approve a Covid-19 vaccine by year’s end.

Major study finds common steroid reduces deaths among patients with severe Covid-19

A cheap, readily available steroid drug reduced deaths by a third in patients hospitalized with Covid-19 in a large study, the first time a therapy has been shown to possibly improve the odds of survival with the condition in the sickest patients. 

Pharmalittle: Cheap steroid reduced deaths in severe Covid-19 patients; what the FDA decision on hydroxychloroquine means

Researchers in England say they have the first evidence that a drug — an inexpensive steroid called dexamethasone — can improve Covid-19 survival.

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

The Food and Drug Administration on Monday said it had withdrawn an emergency approval for use of hydroxychloroquine as a Covid-19 treatment.

Covid-19 and remdesivir: rethinking how we measure a drug’s ‘value’

Just as life science companies are held accountable for the quality of their products, there must be accountability in the methods that researchers use to arrive at the label of value.

Listen: The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-19

Can a virtual conference feel real? Do scientists have a say in their benefactors' business? And what does it take to get remdesivir in the U.S.? Find out on the latest episode of "The Readout LOUD" podcast. Listen now: #TheReadoutLOUD

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy